Categories AlphaGraphs, Cannabis, Earnings
ACB Earnings: Aurora Cannabis reports narrower Q4 loss on higher revenues
Aurora Cannabis, Inc. (NASDAQ: ACB) on Thursday reported a net loss for the fourth quarter of 2024. The company’s revenues moved up 5% year-over-year during the quarter.
The Canada-based recreational marijuana company reported a net loss from continuing operations of C$20.8 million for the fourth quarter, compared to a loss of C$76.2 million in the prior-year period. Adjusted EBITDA was C$1.89 million during the three months, down 5% from the year-ago quarter. Total revenues increased 5% annually to C$67.4 million in Q4.
“Aurora is the largest global medical cannabis company in nationally legal markets and our leadership is best differentiated by serving the diverse needs of patients across the world. In Q4 2024, global medical cannabis net revenue1 increased 20% year-over-year, supported by the recent acquisition of MedReleaf Australia, where we saw significant growth, along with higher sales in Poland and the UK,” said Aurora’s CEO Miguel Martin.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Lamb Weston (LW) Q2 2026 Earnings: Key financials and quarterly highlights
Lamb Weston Holdings, Inc. (NYSE: LW) reported its second quarter 2026 earnings results today. Net sales inched up 1% year-over-year to $1.62 billion. Net sales at constant currency remained flat.
Paychex reports higher Q2 FY26 revenue and earnings; EPS beats estimates
Paychex Inc. (NASDAQ: PAYX) on Friday reported stronger-than-expected adjusted earnings for the second quarter of fiscal 2026. Revenues grew 18% year-over-year. The Rochester-based human capital management solutions provider reported revenues
Key highlights from NIKE’s (NKE) Q2 2026 earnings results
NIKE, Inc. (NYSE: NKE) reported revenues of $12.4 billion for the second quarter of 2026, which were up 1% on a reported basis and flat on a currency-neutral basis compared
